Kohli Prashant
Executive buyerDirector, Chief Executive Officer · Grace Therapeutics, Inc.
Every open-market stock purchase Kohli Prashant has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- GRCEGrace Therapeutics, Inc.
One purchase totalling $214.0K at an average of $2.14 per share. See all insider buying in GRCE →
Avg price paid$2.14Latest price—Market capUnknown
Cluster participation
Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.
- GRCEAug 14 – Nov 5, 20262 insiders$839.2K
- GRCEAug 14 – Oct 26, 20262 insiders$806.2K
- GRCEAug 14 – Oct 19, 20262 insiders$647.6K
- GRCEAug 14 – Oct 16, 20262 insiders$639.6K
- GRCEAug 14 – Oct 12, 20262 insiders$503.4K
- GRCEAug 14 – Oct 5, 20262 insiders$473.7K
- GRCEAug 14 – Sep 29, 20262 insiders$349.9K
- GRCEAug 14 – Sep 23, 20262 insiders$333.5K
- GRCEAug 14 – Sep 23, 20262 insiders$301.8K
- GRCEAug 14 – Sep 9, 20262 insiders$238.2K
- GRCEAug 14 – Sep 9, 20262 insiders$270.1K
All reported buys
Follow new qualifying clusters involving Kohli Prashant or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Kohli Prashant's Form 4 filings on SEC EDGAR (CIK 1946739) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.